The ISC Board has made class 12th syllabus available for the academic year 2026-27. In this article we have explained the ...
Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...
Artificial intelligence played a prominent role at this week’s Bio International Convention in San Diego, the largest biotech ...
SkinTE® would be the first new biologic commercially available in the U.S. for the treatment of a common chronic wound indication in nearly 30 ...
Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective response rate (CR+CRh+PR+CI) of ...
No dose-limiting toxicities, serious adverse events, ICANS, or deaths were reported; infusion-related reactions and CRS were Grade 1–2, and none required glucocorticoids for CRS management Additional ...
Achieved 100% ORR and 83.3% CR rate at dose level 2 following a single infusion in patients with relapsed/refractory B-NHL in an ongoing Phase 1 study No dose-limiting toxicities, serious adverse ...
In its annual Biotech Beyond Borders report, EY projects growth to continue throughout 2026, fueled primarily by the increased volume and value of M&A and licensing deals. (Techa Tungateja/GettyImages ...
LABT READ THE FULL LABT RESEARCH REPORT We are initiating coverage of Lakewood-Amedex Biotherapeutics, Inc. (NASDAQ: LABT) with a valuation of $12.00. Lakewood-Amedex is a clinical-stage ...
Deadline to register is July 21. For more details, visit The IC3 Movement’s 10th Annual Conference and Expo 2026 will be on ...
U.K. pharmaceutical group GSK has entered an agreement to acquire U.S.-based specialist oncology biotech Nuvalent for $10.6 billion. The acquisition could help GSK offset a drop in revenue expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results